A woman who lost over two stone in just four months has revealed how she was able to quit weight-loss jabs for good by 'micro ...

Novo Nordisk saw sales growth for its diabetes and obesity care segment slow in the first half of 2025, confirming investor ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...

The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

Triggered Brand has agreed to pay $18,500 out of a $300,000 judgment after Attorney General William Tong sued the company in ...

Indian pharmaceutical companies are preparing to launch generic versions of Novo Nordisk's weight-loss drug, semaglutide, potentially reducing its price by up to 80%.

Influencer Tana Mongeau has warned against taking the weight loss drug Mounjaro after she experienced severe side effects.

Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy ...

A new study suggests that the anti-obesity drug tirzepatide may help reduce the growth of breast cancer linked to obesity.